Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Identifying non-genetic determinants of malignant clonal fitness at single cell resolution

ABSTRACT: Identifying non-genetic determinants of malignant clonal fitness at single cell resolution

PROVIDER: PRJNA679055 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR13075800_1.fastq.gz	Fastqsanger.gz
	SRR13075800_2.fastq.gz	Fastqsanger.gz
	SRR13075900.fastq.gz	Fastqsanger.gz
	SRR13076000.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 374

Similar Datasets

Identifying non-genetic determinants of malignant clonal fitness at single cell resolution (clonal competition scRNAseq)

Project description:Identifying non-genetic determinants of malignant clonal fitness at single cell resolution (clonal competition scRNAseq)

| PRJNA679061 | ENA

Identifying non-genetic determinants of malignant clonal fitness at single cell resolution (clonal competition barcode-seq)

Project description:Identifying non-genetic determinants of malignant clonal fitness at single cell resolution (clonal competition barcode-seq)

| PRJNA679059 | ENA

Identifying non-genetic determinants of malignant clonal fitness at single cell resolution (clonal competition scRNAseq)

Project description:All cancers emerge following a period of clonal selection and subsequent clonal expansion. Whilst the evolutionary principles imparted by genetic intra-tumour heterogeneity (ITH) are becoming increasingly clear, little is known about the non-genetic mechanisms that contribute to ITH and malignant clonal fitness. Using SPLINTR, a synthetic expressed barcoding strategy, in three clinically relevant mouse models of acute myeloid leukaemia (AML) we find that malignant clonal dominance is a stable and heritable property that is facilitated by the repression of antigen presentation and the increased expression of Slpi, a leukocyte protease inhibitor that has not previously been characterised in AML. Increased transcriptional heterogeneity is a consistent feature enabling clonal fitness in diverse tissue / immune microenvironments and in the context of clonal competition between genetically distinct clones within a uniform microenvironment. Compared to extramedullary sites, leukaemia initiating capacity is most enriched in malignant cells resident within the bone marrow microenvironment and leukaemia stem cells (LSC), like normal haematopoietic stem cells, display heritable clone-intrinsic properties of high, and low clonal output that contribute to the overall tumour mass. Finally, we demonstrate that clonal output does not dictate sensitivity to chemotherapy and both high and low output LSC clones retain marked cellular plasticity enabling them to survive potent therapeutic challenge and persist as minimal residual disease. Together these data provide fundamental insights into the non-genetic transcriptional processes that underpin malignant clonal fitness which may inform future therapeutic strategies.

2021-11-08 | GSE161673 | GEO

Identifying non-genetic determinants of malignant clonal fitness at single cell resolution [chemo scRNAseq]

Project description:Identifying non-genetic determinants of malignant clonal fitness at single cell resolution [chemo scRNAseq]

| PRJNA773261 | ENA

Identifying non-genetic determinants of malignant clonal fitness at single cell resolution [retransplant scRNAseq]

Project description:Identifying non-genetic determinants of malignant clonal fitness at single cell resolution [retransplant scRNAseq]

| PRJNA773263 | ENA

Identifying non-genetic determinants of malignant clonal fitness at single cell resolution (clonal competition barcode-seq)

2021-11-08 | GSE161672 | GEO

Identifying non-genetic determinants of malignant clonal fitness at single cell resolution [chemo scRNAseq]

Project description:All cancers emerge following a period of clonal selection and subsequent clonal expansion. Whilst the evolutionary principles imparted by genetic intra-tumour heterogeneity (ITH) are becoming increasingly clear, little is known about the non-genetic mechanisms that contribute to ITH and malignant clonal fitness. Using SPLINTR, a synthetic expressed barcoding strategy, in three clinically relevant mouse models of acute myeloid leukemia (AML) we find that malignant clonal dominance is a stable and heritable property that is facilitated by the repression of antigen presentation and the increased expression of Slpi, a leukocyte protease inhibitor that has not previously been characterised in AML. Increased transcriptional heterogeneity is a consistent feature enabling clonal fitness in diverse tissue / immune microenvironments and in the context of clonal competition between genetically distinct clones within a uniform microenvironment. Compared to extramedullary sites, leukemia initiating capacity is most enriched in malignant cells resident within the bone marrow microenvironment and leukemia stem cells (LSC), like normal haematopoietic stem cells, display heritable clone-intrinsic properties of high, and low clonal output that contribute to the overall tumour mass. Finally, we demonstrate that clonal output does not dictate sensitivity to chemotherapy and both high and low output LSC clones retain marked cellular plasticity enabling them to survive potent therapeutic challenge and persist as minimal residual disease. Together these data provide fundamental insights into the non-genetic transcriptional processes that underpin malignant clonal fitness which may inform future therapeutic strategies.

2021-11-08 | GSE186305 | GEO

Identifying non-genetic determinants of malignant clonal fitness at single cell resolution [retransplant scRNAseq]

Project description:All cancers emerge following a period of clonal selection and subsequent clonal expansion. Whilst the evolutionary principles imparted by genetic intra-tumour heterogeneity (ITH) are becoming increasingly clear, little is known about the non-genetic mechanisms that contribute to ITH and malignant clonal fitness. Using SPLINTR, a synthetic expressed barcoding strategy, in three clinically relevant mouse models of acute myeloid leukemia (AML) we find that malignant clonal dominance is a stable and heritable property that is facilitated by the repression of antigen presentation and the increased expression of Slpi, a leukocyte protease inhibitor that has not previously been characterised in AML. Increased transcriptional heterogeneity is a consistent feature enabling clonal fitness in diverse tissue / immune microenvironments and in the context of clonal competition between genetically distinct clones within a uniform microenvironment. Compared to extramedullary sites, leukemia initiating capacity is most enriched in malignant cells resident within the bone marrow microenvironment and leukemia stem cells (LSC), like normal haematopoietic stem cells, display heritable clone-intrinsic properties of high, and low clonal output that contribute to the overall tumour mass. Finally, we demonstrate that clonal output does not dictate sensitivity to chemotherapy and both high and low output LSC clones retain marked cellular plasticity enabling them to survive potent therapeutic challenge and persist as minimal residual disease. Together these data provide fundamental insights into the non-genetic transcriptional processes that underpin malignant clonal fitness which may inform future therapeutic strategies.

2021-11-08 | GSE186306 | GEO

Identifying non-genetic determinants of malignant clonal fitness at single cell resolution (secondary leukaemia exome)

Project description:Identifying non-genetic determinants of malignant clonal fitness at single cell resolution (secondary leukaemia exome)

| PRJNA679037 | ENA

Identifying non-genetic determinants of malignant clonal fitness at single cell resolution (primary leukaemia scRNAseq)

Project description:Identifying non-genetic determinants of malignant clonal fitness at single cell resolution (primary leukaemia scRNAseq)

| PRJNA679041 | ENA